Equity Trades portfolio renamed Medical Profits; Three new biotech stocks added: RWLK, EKSO, PH
As much as we loved the idea of making trading recommendations based on short term opportunities we saw in the tech sector, the feedback we got from our subscribers is that they would prefer a longer term, and more focused portfolio. For that reason, we are renaming our Equity Trades portfolio “Medical Profits” to reflect our recently initiated coverage of the biotech sector. Also, we are adding three new stocks to the Medical Profits Portfolio, as follows:
ReWalk Robotics (RWLK), buy limit = $15/stop loss = $9
Ekso Bionics (EKSO), buy limit = $2.10/stop loss = $1.15
Parker-Hannifin (PH), buy limit = $130/stop loss = $105
A complete explanation of these actions can be found in the June 22, 2015 edition of Smart Tech 50 Weekly Movers.
Stock Talk
Add New Comments
You must be logged in to post to Stock Talk OR create an account